Related Experiment Video

Updated: Jun 1, 2026

Modified Radical Neck Dissection for Cervical Metastasis
06:05

Modified Radical Neck Dissection for Cervical Metastasis

Published on: February 20, 2026

Systemic therapy options for unresectable and metastatic chordomas

Silvia Stacchiotti1, Paolo Giovanni Casali

  • 1Sarcoma Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy. silvia.stacchiotti@istitutotumori.mi.it

Current Oncology Reports
|May 18, 2011
PubMed

Insights

Chordoma, a rare slow-growing tumor, presents treatment challenges due to its location. Systemic therapies are crucial for advanced chordoma cases when surgery or radiation is not feasible.

Area of Science:

  • Oncology
  • Rare Cancers
  • Medical Treatments

Background:

  • Chordoma is an rare, slow-growing bone tumor.
  • Primary tumor sites (spine and skull base) complicate surgical treatment.
  • High rates of local relapse (over 50%) and metastasis (at least 20%) are common.

Purpose of the Study:

  • To review current systemic treatments for chordoma.
  • To identify potential future therapeutic targets for this orphan disease.

Main Methods:

  • Literature review of systemic therapies for chordoma.
  • Analysis of current and emerging treatment strategies.

Main Results:

  • Surgery is the primary treatment, but often challenging.
  • Radiation therapy (including proton and carbon ion beams) is used for residual or recurrent disease.
  • Systemic therapy is essential for patients ineligible for surgery or radiation.

Conclusions:

  • Effective systemic treatments are needed for chordoma patients.
  • Further research into novel therapeutic targets is warranted for this rare cancer.

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...